Abbott Laboratories - 41 Year Stock Price History | ABT
Historical daily share price chart and data for Abbott Laboratories since 1983 adjusted for splits and dividends. The latest closing stock price for Abbott Laboratories as of April 18, 2024 is 105.27.
- The all-time high Abbott Laboratories stock closing price was 135.07 on December 27, 2021.
- The Abbott Laboratories 52-week high stock price is 121.64, which is 15.6% above the current share price.
- The Abbott Laboratories 52-week low stock price is 89.67, which is 14.8% below the current share price.
- The average Abbott Laboratories stock price for the last 52 weeks is 106.77.
| Abbott Laboratories Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 113.1947 | 108.7720 | 120.3533 | 105.2700 | 105.2700 | -3.41% |
| 2023 | 102.3739 | 106.3730 | 112.8570 | 89.3049 | 108.9898 | 2.26% |
| 2022 | 107.7620 | 132.7545 | 132.7545 | 92.2780 | 106.5769 | -20.69% |
| 2021 | 115.3444 | 102.5823 | 135.0651 | 100.2375 | 134.3777 | 30.54% |
| 2020 | 89.8688 | 80.5032 | 107.5746 | 58.4065 | 102.9395 | 28.00% |
| 2019 | 74.1102 | 63.2885 | 81.8316 | 60.3016 | 80.4198 | 22.10% |
| 2018 | 58.0944 | 52.5822 | 67.6322 | 50.5674 | 65.8656 | 29.04% |
| 2017 | 43.0805 | 34.1399 | 51.4016 | 34.1399 | 51.0439 | 52.01% |
| 2016 | 35.0537 | 36.6086 | 39.3457 | 31.1890 | 33.5804 | -12.32% |
| 2015 | 39.1476 | 37.4863 | 43.4062 | 33.1142 | 38.2970 | 1.89% |
| 2014 | 33.9100 | 31.2191 | 38.7136 | 29.4402 | 37.5865 | 20.08% |
| 2013 | 28.9334 | 25.7560 | 31.6110 | 25.7560 | 31.3007 | 23.75% |
| 2012 | 24.0969 | 21.5653 | 27.8528 | 20.6737 | 25.2927 | 18.31% |
| 2011 | 19.2825 | 17.8620 | 21.4170 | 16.9433 | 21.3790 | 19.47% |
| 2010 | 18.8233 | 20.0218 | 20.7480 | 16.9869 | 17.8956 | -9.84% |
| 2009 | 17.6919 | 19.3829 | 20.7898 | 15.1428 | 19.8490 | 2.77% |
| 2008 | 19.8579 | 19.9486 | 21.6807 | 17.8955 | 19.3141 | -3.77% |
| 2007 | 19.3634 | 17.3056 | 21.1187 | 17.3056 | 20.0701 | 16.59% |
| 2006 | 15.8357 | 13.7984 | 17.4327 | 13.7984 | 17.2137 | 25.13% |
| 2005 | 15.7524 | 16.0997 | 17.3383 | 13.1286 | 13.7566 | -14.52% |
| 2004 | 14.2278 | 14.9155 | 16.2101 | 12.5856 | 16.0928 | 8.24% |
| 2003 | 13.1146 | 12.6431 | 15.0432 | 10.8822 | 14.8677 | 17.74% |
| 2002 | 14.4124 | 17.4596 | 18.0716 | 9.7607 | 12.6274 | -27.56% |
| 2001 | 15.6094 | 14.9338 | 17.7504 | 13.0766 | 17.4315 | 15.98% |
| 2000 | 12.9038 | 10.7732 | 17.2982 | 9.1407 | 15.0300 | 34.48% |
| 1999 | 13.3891 | 14.9060 | 16.2333 | 10.2530 | 11.1764 | -25.40% |
| 1998 | 12.4818 | 10.2608 | 15.2118 | 10.1467 | 14.9825 | 50.34% |
| 1997 | 9.3615 | 7.6262 | 10.4418 | 7.6262 | 9.9656 | 29.72% |
| 1996 | 6.8446 | 6.2897 | 8.5904 | 5.8443 | 7.6822 | 22.49% |
| 1995 | 5.7868 | 4.8910 | 6.7156 | 4.6905 | 6.2717 | 28.23% |
| 1994 | 4.4378 | 4.3043 | 5.0409 | 3.8994 | 4.8910 | 10.76% |
| 1993 | 3.9914 | 4.5019 | 4.5019 | 3.4230 | 4.4160 | -1.91% |
| 1992 | 4.5410 | 4.9665 | 5.0307 | 3.9918 | 4.5019 | -11.49% |
| 1991 | 3.8424 | 3.1869 | 5.0861 | 2.9308 | 5.0861 | 53.39% |
| 1990 | 2.8073 | 2.5469 | 3.3527 | 2.3177 | 3.3159 | 32.59% |
| 1989 | 2.1720 | 1.7538 | 2.5792 | 1.7133 | 2.5009 | 41.48% |
| 1988 | 1.7192 | 1.7837 | 1.9078 | 1.5782 | 1.7677 | -0.11% |
| 1987 | 2.1084 | 1.7410 | 2.4519 | 1.5772 | 1.7697 | 5.81% |
| 1986 | 1.6077 | 1.2452 | 1.9918 | 1.1676 | 1.6725 | 33.59% |
| 1985 | 0.9981 | 0.7435 | 1.2842 | 0.7321 | 1.2520 | 63.90% |
| 1984 | 0.7855 | 0.8411 | 0.8781 | 0.6953 | 0.7639 | -7.67% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $183.756B | $40.109B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stryker (SYK) | United States | $127.849B | 31.70 |
| Medtronic (MDT) | Ireland | $105.004B | 14.86 |
| Boston Scientific (BSX) | United States | $99.704B | 33.15 |
| EssilorLuxottica (ESLOY) | France | $97.123B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.671B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.031B | 28.96 |
| ResMed (RMD) | United States | $25.568B | 25.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.922B | 16.05 |
| Terumo (TRUMY) | Japan | $24.880B | 35.14 |
| Baxter (BAX) | United States | $20.069B | 14.64 |
| Koninklijke Philips (PHG) | Netherlands | $18.712B | 14.93 |
| Insulet (PODD) | United States | $11.642B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.457B | 0.00 |
| Demant (WILYY) | Denmark | $10.001B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.295B | 24.71 |
| BellRing Brands (BRBR) | United States | $7.115B | 38.25 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.215B | 10.88 |
| Perrigo (PRGO) | Ireland | $4.071B | 11.64 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.378B | 15.97 |
| Envista Holdings (NVST) | United States | $3.367B | 12.80 |
| Green Thumb Industries (GTBIF) | United States | $2.758B | 87.40 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| QuidelOrtho (QDEL) | United States | $2.589B | 9.40 |
| ICU Medical (ICUI) | United States | $2.336B | 17.43 |
| TG Therapeutics (TGTX) | United States | $2.134B | 691.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.943B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| Owens & Minor (OMI) | United States | $1.836B | 17.62 |
| Agios Pharmaceuticals (AGIO) | United States | $1.631B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.486B | 46.29 |
| InMode (INMD) | Israel | $1.465B | 7.59 |
| LeMaitre Vascular (LMAT) | United States | $1.415B | 46.70 |
| AdaptHealth (AHCO) | United States | $1.253B | 9.43 |
| Warby Parker (WRBY) | United States | $1.189B | 0.00 |
| AtriCure (ATRC) | United States | $1.134B | 0.00 |
| MacroGenics (MGNX) | United States | $1.007B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.83 |
| BioLife Solutions (BLFS) | United States | $0.686B | 0.00 |
| Evolus (EOLS) | United States | $0.674B | 0.00 |
| Jin Medical (ZJYL) | China | $0.631B | 0.00 |
| Quanterix (QTRX) | United States | $0.602B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.538B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.533B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.521B | 11.29 |
| PetIQ (PETQ) | United States | $0.469B | 17.50 |
| ZimVie (ZIMV) | United States | $0.417B | 25.55 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Zynex (ZYXI) | United States | $0.388B | 44.70 |
| Surmodics (SRDX) | United States | $0.378B | 40.80 |
| Aurora Cannabis (ACB) | Canada | $0.316B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.303B | 30.08 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 14.80 |
| Ayr Wellness (AYRWF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.175B | 0.00 |
| Veru (VERU) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 21.93 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.05 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Fonar (FONR) | United States | $0.105B | 8.98 |
| Allurion Technologies (ALUR) | United States | $0.104B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.104B | 0.00 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Safety Shot (SHOT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.72 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.36 |
| ProSomnus (OSA) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |